Phase
Condition
Stress
Dyslipidemia
Williams Syndrome
Treatment
N/AClinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Clinical diagnosis of both elevated blood pressure and low density lipoproteincholesterol levels, requiring medication
Exclusion
Exclusion Criteria:
- Patients with blood pressure adequately maintained at goal with or without medication
- Patients currently treated with both amlodipine and atorvastatin or not at bloodpressure or lipid level while taking the highest dose of amlodipine or atorvastatin,respectively
Study Design
Connect with a study center
Pfizer Investigational Site
Buenos Aires, C1181ACH
ArgentinaSite Not Available
Pfizer Investigational Site
St. Leonards, New South Wales 2065
AustraliaSite Not Available
Pfizer Investigational Site
Southport, Queensland 4215
AustraliaSite Not Available
Pfizer Investigational Site
Woolloongabba, Queensland 4102
AustraliaSite Not Available
Pfizer Investigational Site
Heidelberg, Victoria 3084
AustraliaSite Not Available
Pfizer Investigational Site
Melbourne, Victoria 3004
AustraliaSite Not Available
Pfizer Investigational Site
Prahran, Victoria 3181
AustraliaSite Not Available
Pfizer Investigational Site
Fremantle, Western Australia 6160
AustraliaSite Not Available
Pfizer Investigational Site
Belo Horizonte, MG 30130-110
BrazilSite Not Available
Pfizer Investigational Site
Recife, PE 50670-901
BrazilSite Not Available
Pfizer Investigational Site
Botucatu, SP 18618-000
BrazilSite Not Available
Pfizer Investigational Site
Campinas, SP 13012-000
BrazilSite Not Available
Pfizer Investigational Site
Ribeirao Preto, SP 14048-900
BrazilSite Not Available
Pfizer Investigational Site
Sao Paulo, SP 01244-030
BrazilSite Not Available
Pfizer Investigational Site
São Paulo, SP 04038-002
BrazilSite Not Available
Pfizer Investigational Site
São Paulo, SP 04038-002
BrazilSite Not Available
Pfizer Investigational Site
Santiago, Región Metropolitana
ChileSite Not Available
Pfizer Investigational Site
Guatemala, 01015
GuatemalaSite Not Available
Pfizer Investigational Site
Pokfulam Road,
Hong KongSite Not Available
Pfizer Investigational Site
Sai ying Pun,
Hong KongSite Not Available
Pfizer Investigational Site
Hyderabad, Andhra Pradesh 500 033
IndiaSite Not Available
Pfizer Investigational Site
Bangalore, Karnataka 562158
IndiaSite Not Available
Pfizer Investigational Site
Mumbai, Maharashtra 400 007
IndiaSite Not Available
Pfizer Investigational Site
Pune, Maharashtra 411 001
IndiaSite Not Available
Pfizer Investigational Site
New Delhi, 110 026
IndiaSite Not Available
Pfizer Investigational Site
Jakarta, 10430
IndonesiaSite Not Available
Pfizer Investigational Site
Surabaya, 60286
IndonesiaSite Not Available
Pfizer Investigational Site
Jerusalem, 91120
IsraelSite Not Available
Pfizer Investigational Site
Rehovot, 76100
IsraelSite Not Available
Pfizer Investigational Site
Tel Aviv, 64239
IsraelSite Not Available
Pfizer Investigational Site
Tel Hashomer, 52621
IsraelSite Not Available
Pfizer Investigational Site
Amman, 11942
JordanSite Not Available
Pfizer Investigational Site
Seo-gu, Busan 602-739
Korea, Republic ofSite Not Available
Pfizer Investigational Site
Jung-gu, Daegu 700-721
Korea, Republic ofSite Not Available
Pfizer Investigational Site
Dong-gu, Kwangji 501-757
Korea, Republic ofSite Not Available
Pfizer Investigational Site
Anyang-city, Kyungki-do 431-070
Korea, Republic ofSite Not Available
Pfizer Investigational Site
Guri-City, Kyungki-do 471-701
Korea, Republic ofSite Not Available
Pfizer Investigational Site
Gangnam-gu, Seoul 135-710
Korea, Republic ofSite Not Available
Pfizer Investigational Site
Yongdeungpo-gu, Seoul 150-713
Korea, Republic ofSite Not Available
Pfizer Investigational Site
Seoul, 110-799
Korea, Republic ofSite Not Available
Pfizer Investigational Site
Sasat, Zip Code 13110
KuwaitSite Not Available
Pfizer Investigational Site
Beirut,
LebanonSite Not Available
Pfizer Investigational Site
Kubang Kerian, Kelantan 16150
MalaysiaSite Not Available
Pfizer Investigational Site
Seremban, Negeri Sembilan 70400
MalaysiaSite Not Available
Pfizer Investigational Site
Kuching, Sarawak
MalaysiaSite Not Available
Pfizer Investigational Site
Kuala Lumpur, 59100
MalaysiaSite Not Available
Pfizer Investigational Site
Aguascalientes, C.P. 20230
MexicoSite Not Available
Pfizer Investigational Site
Metepec, 52140
MexicoSite Not Available
Pfizer Investigational Site
Mexico, 14000
MexicoSite Not Available
Pfizer Investigational Site
Puebla, 72000
MexicoSite Not Available
Pfizer Investigational Site
San Luis Potosi, 78210
MexicoSite Not Available
Pfizer Investigational Site
Casablanca, 20000
MoroccoSite Not Available
Pfizer Investigational Site
Peshawar, N.w.f.p.
PakistanSite Not Available
Pfizer Investigational Site
Faisalabad, Punjab
PakistanSite Not Available
Pfizer Investigational Site
Islamabad, Punjab
PakistanSite Not Available
Pfizer Investigational Site
Lahore, Punjab
PakistanSite Not Available
Pfizer Investigational Site
Lima, L27
PeruSite Not Available
Pfizer Investigational Site
San Juan, Metro Manila
PhilippinesSite Not Available
Pfizer Investigational Site
Phippine General Hospital, Taft Avenue, Manila City Manila
PhilippinesSite Not Available
Pfizer Investigational Site
Filinvest, Alabang,
PhilippinesSite Not Available
Pfizer Investigational Site
Manila,
PhilippinesSite Not Available
Pfizer Investigational Site
Quezon City, 1100
PhilippinesSite Not Available
Pfizer Investigational Site
Al-Khobar,
Saudi ArabiaSite Not Available
Pfizer Investigational Site
Riyadh, 11426
Saudi ArabiaSite Not Available
Pfizer Investigational Site
Singapore, 119074
SingaporeSite Not Available
Pfizer Investigational Site
Worcester, Cape Province
South AfricaSite Not Available
Pfizer Investigational Site
Arcadia, Pretoria, Gauteng 0083
South AfricaSite Not Available
Pfizer Investigational Site
Midrand, Johannesburg, Gauteng 1685
South AfricaSite Not Available
Pfizer Investigational Site
Sunnyside, Pretoria, Gauteng 0002
South AfricaSite Not Available
Pfizer Investigational Site
4091, Kwa-Zulu Natal
South AfricaSite Not Available
Pfizer Investigational Site
Chatsworth, Natal 4092
South AfricaSite Not Available
Pfizer Investigational Site
Cape Town, 7405
South AfricaSite Not Available
Pfizer Investigational Site
Gauteng, 2059
South AfricaSite Not Available
Pfizer Investigational Site
Kwa-Zulu Natal,
South AfricaSite Not Available
Pfizer Investigational Site
Niao-Sung Hsiang, Kaohsiung 833
TaiwanSite Not Available
Pfizer Investigational Site
Guei-Shan Shiang, Tau-Yuan Shian 333
TaiwanSite Not Available
Pfizer Investigational Site
Changhua City, 500
TaiwanSite Not Available
Pfizer Investigational Site
Taipei, 100
TaiwanSite Not Available
Pfizer Investigational Site
KHET Rajathevee, Bangkok 10400
ThailandSite Not Available
Pfizer Investigational Site
Bangkok, 10400
ThailandSite Not Available
Pfizer Investigational Site
Chiang Mai, 50200
ThailandSite Not Available
Pfizer Investigational Site
Tunis,
TunisiaSite Not Available
Pfizer Investigational Site
Cebeci, Ankara 06100
TurkeySite Not Available
Pfizer Investigational Site
Sihhiye, Ankara 06100
TurkeySite Not Available
Pfizer Investigational Site
Unknown, Gaziantep
TurkeySite Not Available
Pfizer Investigational Site
Haydarpasa, Istanbul 81010
TurkeySite Not Available
Pfizer Investigational Site
Alsancak, Izmir
TurkeySite Not Available
Pfizer Investigational Site
Talas, Kayseri 38039
TurkeySite Not Available
Pfizer Investigational Site
Adana, 01330
TurkeySite Not Available
Pfizer Investigational Site
Antalya, 07059
TurkeySite Not Available
Pfizer Investigational Site
Diyarbakir, 21280
TurkeySite Not Available
Pfizer Investigational Site
Istanbul,
TurkeySite Not Available
Pfizer Investigational Site
Abu Dhabi,
United Arab EmiratesSite Not Available
Pfizer Investigational Site
Dubai,
United Arab EmiratesSite Not Available
Pfizer Investigational Site
Sharjah,
United Arab EmiratesSite Not Available
Pfizer Investigational Site
,
Site Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.